The following tables provide details of selected Condensed Consolidated Balance Sheet line items (in millions):


	As of
Accounts receivable, net	September 30, 2026		December 31, 2025
Trade accounts receivable, net	$	1,471.8	$	1,357.7


Unbilled accounts receivable and other	278.0		196.3
Sales returns and allowances	(28.5)		(26.7)
Total accounts receivable, net	$	1,721.3	$	1,527.3


	As of
Inventory	September 30, 2026		December 31, 2025
Raw materials	$	652.3	$	561.1
Work-in-process	333.2		287.9
Finished goods	1,142.7		991.0
Total inventory	$	2,128.2	$	1,840.0


	As of
Prepaids and other current assets	September 30, 2026		December 31, 2025
Net investment in sales-type leases – short-term	$	103.7	$	100.9
Prepaid taxes	80.6		15.3

Other prepaids and other current assets	352.0		361.1


Total prepaids and other current assets	$	536.3	$	477.3


	As of
Other accrued liabilities – short-term	September 30, 2026		December 31, 2025
Income and other taxes payable	$	218.8	$	125.4
Accrued construction-related capital expenditures	62.6		58.3
Litigation-related accruals	463.2		6.2

Other accrued liabilities	461.8		406.1



Total other accrued liabilities – short-term	$	1,206.4	$	596.0


	As of
Other long-term liabilities	September 30, 2026		December 31, 2025
Income taxes payable – long-term	$	273.6	$	193.6
Deferred revenue – long-term	128.2		91.4
Other long-term liabilities	296.5		225.8
Total other long-term liabilities	$	698.3	$	510.8

Amounts included in restricted cash primarily relate to the Company’s insurance programs and certain employee-related benefits. The following table provides details of total cash, cash equivalents, and restricted cash as of the periods presented (in millions):


	As of
	September 30, 2026		December 31, 2025
Cash and cash equivalents	$	2,978.1	$	3,368.0

Restricted cash within other current assets	29.3		24.4
Restricted cash within other assets	15.0		15.0
Total cash, cash equivalents, and restricted cash	$	3,022.4	$	3,407.4